Text of OK SB 252 (2023)
Health care; prohibiting certain medical treatment for minors; providing administrative penalty. Effective date.
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
2,757 characters
Req. No. 437
Page 1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
STATE OF OKLAHOMA
1st Session of the 59th Legislature (2023)
SENATE BILL 252
By: Dahm
AS INTRODUCED
An Act relating to health care; prohibiting certain
medical treatment for minors; providing penalty;
defining term; providing for codification; and
providing an effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 2607 of Title 63, unless there
is created a duplication in numbering, reads as follows:
A. A person under the age of eighteen (18) years is prohibited
from undergoing gender reassignment medical treatment in this state.
B. A health care professional who intentionally performs gender
reassignment medical treatment on a person who is under the age of
eighteen (18) years is subject to professional discipline by the
State Board of Medical Licensure and Supervision, the State Board of
Osteopathic Examiners, or the applicable health care professional
licensing board, up to and including suspension or revocation of any
license or certification required to practice.
Req. No. 437
Page 2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
C. “Gender reassignment medical treatment” means any health
care to facilitate the transitioning of a patient’s assigned gender
identity on the patient’s birth certificate, to the gender identity
experienced and defined by the patient. The term shall include, but
not be limited to:
1. Interventions to suppress the development of endogenous
secondary sex characteristics;
2. Interventions to align the patient’s appearance or physical
body with the patient’s gender identity; and
3. Interventions to alleviate symptoms of clinically
significant distress resulting from gender dysphoria, as defined in
the Diagnostic and Statistical Manual of Mental Disorders, 5th
Edition. The term does not include behavioral health care services,
such as mental health counseling or medications to treat depression,
anxiety, or similar disorders, provided the medication does not have
long-term altering effects on the gender of a minor.
SECTION 2. This act shall become effective November 1, 2023.
59-1-437
DC
1/10/2023 12:52:09 PM